|
US6949244B1
(en)
|
1995-12-20 |
2005-09-27 |
The Board Of Trustees Of The University Of Kentucky |
Murine monoclonal anti-idiotype antibody 11D10 and methods of use thereof
|
|
DK1345959T3
(da)
*
|
2000-11-20 |
2011-09-05 |
Univ Illinois |
Membranscaffoldproteiner
|
|
US7622437B2
(en)
*
|
2000-11-20 |
2009-11-24 |
The Board Of Trustees Of The University Of Illinois |
Tissue factor compositions and methods
|
|
US7592008B2
(en)
*
|
2000-11-20 |
2009-09-22 |
The Board Of Trustees Of The University Of Illinois, A Body Corporate And Politic Of The State Of Illinois |
Membrane scaffold proteins
|
|
TWI433693B
(zh)
|
2003-02-14 |
2014-04-11 |
Childrens Hosp & Res Ct Oak |
親脂藥物傳送媒介物及其使用方法
|
|
US7219017B2
(en)
|
2003-09-11 |
2007-05-15 |
Franco Vitaliano |
Quantum information processing elements and quantum information processing platforms using such elements
|
|
US7219018B2
(en)
*
|
2003-09-11 |
2007-05-15 |
Franco Vitaliano |
Quantum information processing elements and quantum information processing platforms using such elements
|
|
US7216038B2
(en)
|
2003-09-11 |
2007-05-08 |
Franco Vitaliano |
Quantum information processing elements and quantum information processing platforms using such elements
|
|
US7393924B2
(en)
*
|
2004-01-06 |
2008-07-01 |
Franco Vitaliano |
Smart bio-nanoparticle elements
|
|
ITRM20040357A1
(it)
*
|
2004-07-16 |
2004-10-16 |
Paolo Abrescia |
Metodo per identificare agenti modulanti del metabolismo di molecole steroidee.
|
|
JP2008507288A
(ja)
*
|
2004-07-23 |
2008-03-13 |
アクセルロン ファーマ インコーポレーテッド |
ActRII受容体ポリペプチド、方法、および組成物
|
|
EP1812032A4
(en)
*
|
2004-10-27 |
2009-09-02 |
Univ Illinois |
TISSUE FACTOR COMPOSITION AND RELATED METHODS
|
|
JP2009521209A
(ja)
*
|
2005-09-27 |
2009-06-04 |
ライフ テクノロジーズ コーポレーション |
アポリポタンパク質及びホスホリピド−アポリポタンパク質粒子を含む、膜タンパク質用のインビトロタンパク質合成システム
|
|
US20070117179A1
(en)
*
|
2005-09-27 |
2007-05-24 |
Invitrogen Corporation |
In vitro protein synthesis systems for membrane proteins that include adolipoproteins and phospholipid-adolipoprotein particles
|
|
ES2649983T3
(es)
|
2005-11-23 |
2018-01-16 |
Acceleron Pharma, Inc. |
Antagonistas de activina-ActRIIa en su uso para promover el crecimiento óseo
|
|
US8128933B2
(en)
|
2005-11-23 |
2012-03-06 |
Acceleron Pharma, Inc. |
Method of promoting bone growth by an anti-activin B antibody
|
|
US8895016B2
(en)
|
2006-12-18 |
2014-11-25 |
Acceleron Pharma, Inc. |
Antagonists of activin-actriia and uses for increasing red blood cell levels
|
|
MX2009008222A
(es)
|
2007-02-01 |
2009-10-12 |
Acceleron Pharma Inc |
Antagonistas de activina-actriia y usos para tratar o prevenir cancer de mama.
|
|
TW201803890A
(zh)
|
2007-02-02 |
2018-02-01 |
艾瑟勒朗法瑪公司 |
衍生自ActRIIB的變體與其用途
|
|
EA018221B1
(ru)
|
2007-02-09 |
2013-06-28 |
Акселерон Фарма Инк. |
АНТАГОНИСТЫ АКТИВИНА-ActRIIa И ПРИМЕНЕНИЕ ДЛЯ СТИМУЛЯЦИИ РОСТА КОСТИ У БОЛЬНЫХ РАКОМ
|
|
EP2118129A4
(en)
*
|
2007-03-01 |
2010-04-28 |
Life Technologies Corp |
ISOLATED PHOSPHOLIPID PROTEIN PARTICLES
|
|
WO2008141230A1
(en)
*
|
2007-05-09 |
2008-11-20 |
Lawrence Livermore National Security, Llc |
Methods and systems for monitoring production of a target protein in a nanolipoprotein particle
|
|
CN101861161B
(zh)
|
2007-09-18 |
2017-04-19 |
阿塞勒隆制药公司 |
活化素‑actriia拮抗剂和减少或抑制fsh分泌的用途
|
|
US8907061B2
(en)
|
2008-01-11 |
2014-12-09 |
Lawrence Livermore National Security, Llc. |
Nanolipoprotein particles and related methods and systems for protein capture, solubilization, and/or purification
|
|
US8999320B2
(en)
*
|
2008-01-30 |
2015-04-07 |
The Rockefeller University |
Nanoscale bound bilayers, methods of use and production
|
|
EP2288336B8
(en)
*
|
2008-04-25 |
2017-03-22 |
Northwestern University |
Nanostructures suitable for sequestering cholesterol
|
|
US9303273B2
(en)
|
2008-05-09 |
2016-04-05 |
Lawrence Livermore National Security, Llc |
Nanolipoprotein particles comprising a natural rubber biosynthetic enzyme complex and related products, methods and systems
|
|
US8883729B2
(en)
|
2008-05-22 |
2014-11-11 |
Lawrence Livermore National Security, Llc |
Nanolipoprotein particles and related compositions, methods and systems
|
|
US8268796B2
(en)
|
2008-06-27 |
2012-09-18 |
Children's Hospital & Research Center At Oakland |
Lipophilic nucleic acid delivery vehicle and methods of use thereof
|
|
US8216997B2
(en)
|
2008-08-14 |
2012-07-10 |
Acceleron Pharma, Inc. |
Methods for increasing red blood cell levels and treating anemia using a combination of GDF traps and erythropoietin receptor activators
|
|
TW201803586A
(zh)
|
2008-08-14 |
2018-02-01 |
艾瑟勒朗法瑪公司 |
使用gdf阱以增加紅血球水平
|
|
KR100991486B1
(ko)
|
2008-10-08 |
2010-11-04 |
성균관대학교산학협력단 |
아미노산 태그가 신장된 apoA-I 단백질 및 인지질을 이용한 막 단백질의 고체 표면 고정화 방법
|
|
US20100233270A1
(en)
|
2009-01-08 |
2010-09-16 |
Northwestern University |
Delivery of Oligonucleotide-Functionalized Nanoparticles
|
|
US11096901B2
(en)
|
2009-03-06 |
2021-08-24 |
Metaqor Llc |
Dynamic bio-nanoparticle platforms
|
|
US11235062B2
(en)
*
|
2009-03-06 |
2022-02-01 |
Metaqor Llc |
Dynamic bio-nanoparticle elements
|
|
KR20120049214A
(ko)
|
2009-06-08 |
2012-05-16 |
악셀레론 파마 인코포레이티드 |
발열성 지방세포를 증가시키는 방법
|
|
KR20180026795A
(ko)
|
2009-06-12 |
2018-03-13 |
악셀레론 파마 인코포레이티드 |
절두된 ActRIIB-FC 융합 단백질
|
|
JP5481746B2
(ja)
*
|
2009-09-28 |
2014-04-23 |
公益財団法人東洋食品研究所 |
フロクマリン類の含有量を低減したイチジクの製造方法
|
|
US10525152B2
(en)
|
2009-10-09 |
2020-01-07 |
Signablok, Inc. |
Methods and compositions for targeted imaging
|
|
US12419839B2
(en)
|
2009-10-09 |
2025-09-23 |
Signablok, Inc. |
Methods and compositions for targeted delivery of protein fragments
|
|
EP3332796A1
(en)
|
2009-11-17 |
2018-06-13 |
Acceleron Pharma Inc. |
Actriib proteins and variants and uses therefore relating to utrophin induction for muscular dystrophy therapy
|
|
WO2011082178A1
(en)
|
2009-12-29 |
2011-07-07 |
Nanosense Inc. |
Fet - based nanotube sensor array
|
|
AU2011207563B2
(en)
|
2010-01-19 |
2016-03-10 |
Northwestern University |
Synthetic nanostructures including nucleic acids and/or other entities
|
|
US8865877B2
(en)
*
|
2010-03-19 |
2014-10-21 |
Northwestern University |
Compositions and methods for solubilizing membrane proteins without the use of detergent
|
|
AU2011326586A1
(en)
|
2010-11-08 |
2013-05-30 |
Acceleron Pharma, Inc. |
ActRIIA binding agents and uses thereof
|
|
HUE042314T2
(hu)
|
2011-02-07 |
2019-06-28 |
Cerenis Therapeutics Holding Sa |
Lipoprotein komplexek és azok gyártása és alkalmazásai
|
|
US8715987B2
(en)
*
|
2011-05-02 |
2014-05-06 |
New England Biolabs, Inc. |
Solubilized phospholipids for stabilizing nucleic acid polymerases
|
|
GB201110272D0
(en)
|
2011-06-17 |
2011-08-03 |
Isis Innovation |
Metod of detection by mass spectrometry
|
|
US9644038B2
(en)
|
2011-12-21 |
2017-05-09 |
The Regents Of The University Of California |
Apolipoprotein nanodiscs with telodendrimer
|
|
BR112014028645A2
(pt)
*
|
2012-05-16 |
2017-06-27 |
Rana Therapeutics Inc |
composições e métodos para modulação da expressão de apoa1 e abca1.
|
|
BR112014028631A2
(pt)
|
2012-05-16 |
2017-10-17 |
Rana Therapeutics Inc |
composições e métodos para modulação da expressão da família de genes da hemoglobina
|
|
EA201492122A1
(ru)
|
2012-05-16 |
2015-10-30 |
Рана Терапьютикс, Инк. |
Композиции и способы для модулирования экспрессии utrn
|
|
EA201492116A1
(ru)
|
2012-05-16 |
2015-05-29 |
Рана Терапьютикс, Инк. |
Композиции и способы для модулирования экспрессии mecp2
|
|
SG11201407483YA
(en)
|
2012-05-16 |
2014-12-30 |
Rana Therapeutics Inc |
Compositions and methods for modulating smn gene family expression
|
|
AU2013262699A1
(en)
|
2012-05-16 |
2015-01-22 |
Rana Therapeutics, Inc. |
Compositions and methods for modulating ATP2A2 expression
|
|
US10837014B2
(en)
|
2012-05-16 |
2020-11-17 |
Translate Bio Ma, Inc. |
Compositions and methods for modulating SMN gene family expression
|
|
US10195249B2
(en)
|
2012-11-02 |
2019-02-05 |
Celgene Corporation |
Activin-ActRII antagonists and uses for treating bone and other disorders
|
|
EP2745834B1
(en)
|
2012-12-18 |
2016-09-28 |
Jens Frauenfeld |
Salipro particles
|
|
SI3043814T1
(sl)
|
2013-09-13 |
2021-04-30 |
Salipro Biotech AB, Greenhouse Labs |
Antigen in postopek za proizvodnjo le-tega
|
|
WO2015066080A2
(en)
*
|
2013-10-28 |
2015-05-07 |
The Regents Of The University Of California |
Lipid co-factor essential for cell density signaling
|
|
TR201908550T4
(tr)
|
2014-06-04 |
2019-07-22 |
Exicure Inc |
Profilaktik veya terapötik uygulamalar için lipozomal sferik nükleik asitler tarafından immün modülatörlerin çok değerlikli teslimi.
|
|
CN114699529A
(zh)
|
2014-06-13 |
2022-07-05 |
阿塞勒隆制药公司 |
用于治疗溃疡的方法和组合物
|
|
CA3163156C
(en)
*
|
2014-07-31 |
2025-07-08 |
Illumina, Inc. |
HYBRID NANOPORE SENSORS
|
|
WO2016025781A1
(en)
*
|
2014-08-15 |
2016-02-18 |
Cornell University |
Compositions and methods for making water-soluble integral membrane proteins
|
|
WO2016028940A1
(en)
|
2014-08-19 |
2016-02-25 |
Northwestern University |
Protein/oligonucleotide core-shell nanoparticle therapeutics
|
|
WO2016049061A1
(en)
|
2014-09-22 |
2016-03-31 |
Lawrence Livermore National Security, Llc |
Electrochemical flow-cell for hydrogen production and nicotinamide co-factor dependent target reduction, and related methods and systems
|
|
CR20170181A
(es)
|
2014-10-06 |
2017-05-31 |
Exicure Inc |
Compuestos anti-tnf
|
|
MA41052A
(fr)
|
2014-10-09 |
2017-08-15 |
Celgene Corp |
Traitement d'une maladie cardiovasculaire à l'aide de pièges de ligands d'actrii
|
|
US11213593B2
(en)
|
2014-11-21 |
2022-01-04 |
Northwestern University |
Sequence-specific cellular uptake of spherical nucleic acid nanoparticle conjugates
|
|
JP2018501307A
(ja)
|
2014-12-03 |
2018-01-18 |
セルジーン コーポレイション |
アクチビン−ActRIIアンタゴニスト及び貧血を治療するための使用
|
|
US10078092B2
(en)
|
2015-03-18 |
2018-09-18 |
Northwestern University |
Assays for measuring binding kinetics and binding capacity of acceptors for lipophilic or amphiphilic molecules
|
|
WO2016187118A1
(en)
|
2015-05-16 |
2016-11-24 |
Batavia Biosciences Inc. |
Thermostable vaccines based on ether lipids and native viral envelope proteins
|
|
WO2017035326A1
(en)
|
2015-08-25 |
2017-03-02 |
Lawrence Livermore National Security, Llc |
Stable nanolipoprotein particles and related compositions methods and systems
|
|
WO2017044899A1
(en)
|
2015-09-11 |
2017-03-16 |
Lawrence Livermore National Security, Llc |
Synthetic apolipoproteins, and related compositions methods and systems for nanolipoprotein particles formation
|
|
CN108779181A
(zh)
|
2015-10-16 |
2018-11-09 |
国立输血研究院 |
生产红细胞蛋白质的方法
|
|
EP3368089B1
(en)
|
2015-10-26 |
2025-11-05 |
Translate Bio Ma, Inc. |
Nanoparticle formulations for delivery of nucleic acid complexes
|
|
US11053301B2
(en)
*
|
2016-07-18 |
2021-07-06 |
President And Fellows Of Harvard College |
Methods and compositions relating to covalently circularized nanodiscs
|
|
EP3284460A1
(en)
|
2016-08-19 |
2018-02-21 |
Salipro Biotech AG |
Saposin lipoprotein particles and libraries from crude membranes
|
|
US12083223B2
(en)
|
2017-05-02 |
2024-09-10 |
Lawrence Livermore National Security, Llc |
Nanolipoprotein particles and related compositions methods and systems for loading RNA
|
|
US11207422B2
(en)
|
2017-05-02 |
2021-12-28 |
Lawrence Livermore National Security, Llc |
MOMP telonanoparticles, and related compositions, methods and systems
|
|
KR101994279B1
(ko)
*
|
2017-11-03 |
2019-06-28 |
서울대학교산학협력단 |
후각 수용체 단백질을 포함하는 나노디스크의 제조방법과 이에 의하여 제조된 후각 수용체 단백질을 포함하는 나노디스크
|
|
WO2019200240A1
(en)
|
2018-04-13 |
2019-10-17 |
Board Of Regents, The University Of Texas System |
Transmembrane stem cell factor (tm-scf) lipid nanocarriers and methods of use thereof
|
|
US12474272B2
(en)
|
2019-01-25 |
2025-11-18 |
Arizona Board Of Regents On Behalf Of The University Of Arizona |
Optical cavity surface bioconjunction using lipid membranes for label free, ultrasensitive detection of biomolecules
|
|
EP3725304A1
(en)
|
2019-04-15 |
2020-10-21 |
Salipro Biotech AB |
Production of salipro particles
|
|
CN110305205A
(zh)
*
|
2019-07-11 |
2019-10-08 |
江西晶美瑞生物医药有限公司 |
一种用于生产膜蛋白抗原的纳米圆盘的制备方法
|
|
KR20210035752A
(ko)
*
|
2019-09-24 |
2021-04-01 |
성균관대학교산학협력단 |
항-바이러스 활성이 향상된 나노천공자
|
|
CN114630891B
(zh)
|
2019-10-30 |
2025-06-10 |
豪夫迈·罗氏有限公司 |
用于生物纳米孔的组装的方法和组合物
|
|
US12596108B2
(en)
*
|
2020-02-06 |
2026-04-07 |
Arizona Board Of Regents On Behalf Of The University Of Arizona |
Automated lipid exchange-mass spectrometry systems and methods
|
|
CA3191727A1
(en)
*
|
2020-08-14 |
2022-02-17 |
Mayo Foundation For Medical Education And Research |
Methods and materials for tissue ablation
|
|
IL303865A
(en)
|
2020-12-23 |
2023-08-01 |
Regeneron Pharma |
Methods for obtaining antibodies that bind transmembrane proteins and cells that produce them
|
|
KR102539699B1
(ko)
*
|
2021-04-19 |
2023-06-12 |
리셉텍 주식회사 |
Gpcr이 포함된 나노디스크가 장착된 항체 스크리닝 키트 및 이를 이용한 항체 의약품 스크리닝 방법
|
|
EP4467564A4
(en)
*
|
2022-01-28 |
2026-01-21 |
Research & Business Found Sungkyunkwan Univ |
LIPID NANOPARTICLE LINKED TO AN ANTIBODY COMPRISING AN ANTIBODY LINKED TO A MEMBRANE SCAFFOLDING PROTEIN
|
|
AU2024246785A1
(en)
|
2023-03-30 |
2025-09-11 |
F. Hoffmann-La Roche Ag |
Modulation of target molecule-lipid bilayer interactions
|
|
WO2025137409A1
(en)
*
|
2023-12-21 |
2025-06-26 |
University Of Florida Research Foundation, Incorporated |
Supercharged lipid nanodiscs and methods of use
|
|
WO2025257777A1
(en)
*
|
2024-06-12 |
2025-12-18 |
Janssen Biotech, Inc. |
Materials and methods for improved three-dimensional immunity
|